Loading data for FMS — first visit, this takes a few seconds.

Preisalarm

Fresenius Medical Care AG (FMS)

NYSE: FMS · Echtzeitkurs · USD

23.50

-0.27 (-1.14%)

Zum Schluss: Aug 19, 2026, 12:06 PM

-1.14% (1D)

Geld	23.7
Marktkapitalisierung	12.69 Mrd
Umsatz (TTM)	19.43 Mrd
Nettogewinn (TTM)	937.78 Mio
Beta	0.84
EPS (ttm)	1.92
KGV (TTM)	12.42
Forward-KGV	6.57
KBV (TTM)	0.87
KUV (TTM)	0.65
Earnings Date	Nov 3, 2026

Brief	n/a
Volumen	492,004
Ø Vol. (20D)	734,881
Eröffnung	23.77
Vortagesschluss	23.77
Tagesspanne	23.50 - 23.86
52-Wk Range	20.02 - 27.64
Analyst	n/a
Kursziel	n/a
Dividenden	$0.87 (3.7%)
Ex-Dividenden-Datum	22. Mai 2026

Über FMS

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient'...

[Mehr lesen]

Branche Medical Care Facilities

Sektor Healthcare

IPO Datum Sep 17, 1996

Mitarbeiter 107,226

Börse NYSE

Tickersymbol FMS

Website https://www.freseniusmedicalcare.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Fresenius Medical Care 19.63 Mrd, ein Anstieg von 1.51% im Vergleich zum Vorjahr (19.34 Mrd). Der Gewinn lag bei 978.37 Mio, ein Anstieg von 81.88 %.

Finanzberichte

Gewinnüberraschung

Fresenius Medical Care hat die Quartalszahlen am Aug 3, 2026 veröffentlicht:

Umsatz von n/a verfehlt die Erwartungen um $0, mit -100.00% Rückgang im Jahresvergleich.

EPS von 0.56 übertrifft die Erwartungen um 0.06, mit 21.74% Wachstum im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Fresenius Medical Care AG wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 3, 2026, während der Handelszeiten.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 1 Woche · Motley Fool

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

U.S. referral execution gap offset by strong margin expansion and transformation savings.

vor 1 Woche · Zacks

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.

vor 2 Wochen · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF

Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates the 5008X CAREsystem and ...

vor 2 Wochen · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns

Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest the market may be pricing it on the ch...

vor 2 Wochen · Simply Wall St.

Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?

Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer of the Care Delivery segment, res...

Seite 1 von 2

Fresenius Medical Care AG (FMS)